Biopharmaceutical Plant
- All
- News
-
China Biopharma Plant Leak Infects Thousands With Bacterial Disease
Another 1,401 people tested as an early positive for the disease, and health authorities said there was no evidence of person-to-person transmission so far.
-
Samsung Unit to Invest $736 Million in Manufacturing Plant
Samsung Biologics, an unlisted arm of South Korea's Samsung Group, said on Friday it would invest 850 billion won ($736 million) to build a manufacturing facility, as the conglomerate steps up its expansion in the biopharmaceutical sector.
-
China Biopharma Plant Leak Infects Thousands With Bacterial Disease
Another 1,401 people tested as an early positive for the disease, and health authorities said there was no evidence of person-to-person transmission so far.
-
Samsung Unit to Invest $736 Million in Manufacturing Plant
Samsung Biologics, an unlisted arm of South Korea's Samsung Group, said on Friday it would invest 850 billion won ($736 million) to build a manufacturing facility, as the conglomerate steps up its expansion in the biopharmaceutical sector.
